Case Study: a Fortune 500 pharmaceutical company achieves 10% Scope 3 emissions reduction with Syren's sustainability tracker

Fortune 500 Pharmaceutical Company cuts Scope 3 logistics emissions by 10% with Syren

A Fortune 500 pharmaceutical company faced the challenge of measuring and reducing its Scope 3 logistics emissions, as it lacked a system to track this data. Data was fragmented across different platforms, making it difficult to balance sustainability goals with operational costs. The company turned to Syren for a solution using its sustainability tracker service to gain visibility and comply with GLEC standards.

Syren implemented a solution that integrated the client's data via APIs and applied GLEC-compliant calculations to measure emissions. Custom dashboards provided insights into high-emission routes and trends. As a result, the pharmaceutical company achieved a 10% reduction in its upstream value chain emissions and saved a significant number of man-hours through automation, thanks to Syren's platform.